You have 9 free searches left this month | to do more
Showing 1 - 25 of
1,873 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Decitabine, Venetoclax, and Ponatinib for the Treatment of Philadelphia Chromosome-Positive Acute Myeloid Leukemia or Myeloid Blast Phase or Accelerated Phase Chronic Myelogenous Leukemia
Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-25
Feb 25, 2022
M
MAX-40279 in Subjects With Acute Myelogenous Leukemia (AML)
Recruiting
  • Acute Myelogenous Leukemia (AML)
  • Darlinghurst, New South Wales, Australia
  • +3 more
2022-01-18
Jan 18, 2022
M
Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or BCR-ABL1 Positive Early Chronic Phase Chronic Myelogenous Leukemia
Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
2022-01-19
Jan 19, 2022
M
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Recruiting
  • Chronic Myelogenous Leukemia
  • Chart Review
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2022-02-08
Feb 8, 2022
A
Gleevec as Maintenance Therapy After Cytogenetic Response With Nilotinib in Newly Diagnosed Chronic Myelogenous Leukemia
Recruiting
  • Chronic Myelogenous Leukemia
  • Beirut, Lebanon
    American University of Beirut Medical Center
2022-02-14
Feb 14, 2022
G
Gentulizumab in Relapsed/Refractory Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Recruiting
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndromes
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
2022-02-22
Feb 22, 2022
M
Dasatinib in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia
Active, not recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
2021-05-05
May 5, 2021
C
Integrating Geriatric Assessment for Older Patients Diagnosed With Acute Myelogenous Leukemia - 2020
Completed
  • Acute Myeloid Leukemia
  • modified Geriatric Assessment (mGA)
  • Birmingham, Alabama
    University of Alabama Birmingham
2022-01-13
Jan 13, 2022
L
LCI-HEM-SPEC-001: Tissue Collection for Genetic Analysis of Acute Myelogenous Leukemia - 2016
Completed
  • Leukemia, Myelogenous, Acute
    • Charlotte, North Carolina
      Levine Cancer Institute
    2021-11-05
    Nov 5, 2021
    A
    A Study of APTO-253 in Patients With Relapsed or Refractory AML or MDS - 2021
    Terminated
    • Acute Myelogenous Leukemia in Relapse
    • +4 more
    • Tucson, Arizona
    • +12 more
    2022-01-06
    Jan 6, 2022
    A
    Eltrombopag in Elderly Acute Myelogenous Leukemia (AML) - 2015
    Terminated
    Has Results
    • Acute Myelogenous Leukemia (AML)
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    2021-07-14
    Jul 14, 2021
    M
    Study of MAX-40279 in Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)
    Recruiting
    • AML
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, Zhejiang University
    2022-01-18
    Jan 18, 2022
    M
    Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCT
    Active, not recruiting
    • Acute Myelogenous Leukemia (AML)
    • Myelodysplastic Syndrome (MDS)
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    2022-02-25
    Feb 25, 2022
    N
    Immunochemotherapy and AlloSCT in Patients With High Risk CD33+ AML/MDS
    Active, not recruiting
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
    • Gemtuzumab Ozogamicin
    • Valhalla, New York
      New York Medical College
    2021-11-11
    Nov 11, 2021
    N
    A Phase 1 Study of SH1573 Capsules in Subjects With Refractory or Relapsed Acute Myelogenous Leukemia
    Recruiting
    • Acute Myelogenous Leukemia
    • SH1573 Capsules
    • Fuzhou, Fujian, China
    • +1 more
    2021-03-17
    Mar 17, 2021
    S
    CD123-Directed Autologous T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
    Recruiting
    • AML
    • +3 more
    • CD123-CAR T
    • +4 more
    • Memphis, Tennessee
      St. Jude Children's Hospital
    2021-08-06
    Aug 6, 2021
    M
    Pevonedistat, Azacitidine (or Decitabine), and Venetoclax for the Treatment of Patients With Acute Myelogenous Leukemia
    Active, not recruiting
    • Acute Myelogenous Leukemia
    • Rochester, Minnesota
    • +1 more
    2021-09-21
    Sep 21, 2021
    A
    A Phase I-II Open Label Non-Randomized Study Using TL32711 for Patients With Acute Myelogenous Leukemia, Myelodysplastic Syndrome and Acute Lymphoblastic Leukemia - 2015
    Terminated
    Has Results
    • Acute Myelogenous Leukemia
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    2021-06-23
    Jun 23, 2021
    M
    Open Label NK Cell Infusion (FATE-NK100) With Subq IL-2 in Adults With AML - 2020
    Completed
    • Refractory Acute Myelogenous Leukemia
    • Relapsed Acute Myelogenous Leukemia
    • FATE-NK100
    • Minneapolis, Minnesota
      University of Minnesota, Masonic Cancer Center
    2021-03-10
    Mar 10, 2021
    J
    Pevonedistat and Low Dose Cytarabine in Adult Patients With AML and MDS - 2021
    Completed
    • Acute Myelogenous Leukemia
    • +3 more
    • Miami, Florida
      University of Miami
    2021-12-07
    Dec 7, 2021
    J
    Bortezomib and Doxil for the Treatment of Patients With Acute Myelogenous Leukemia - 2019
    Completed
    Has Results
    • Acute Myelogenous Leukemia
    • Sacramento, California
      University of California Comprehensive Cancer Center
    2021-02-04
    Feb 4, 2021
    T
    Safety and Early Efficacy Study of TBX-2400 in Patients With AML or Myelofibrosis
    Not yet recruiting
    • Myelofibrosis
    • Acute Myelogenous Leukemia
    • TBX-2400
    • Zagreb, Croatia
    • +1 more
    2022-01-11
    Jan 11, 2022
    U
    CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia
    Recruiting
    • Acute Myelogenous Leukemia (AML) Due to Therapy
    • Acute Myeloid Leukemia With Myelodysplasia-Related Changes
    • La Jolla, California
    • +2 more
    2021-04-09
    Apr 9, 2021
    S
    Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL - 2018
    Terminated
    • Acute Myelogenous Leukemia
    • +2 more
    • Oklahoma City, Oklahoma
    • +1 more
    2022-03-17
    Mar 17, 2022
    M
    Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive PC Positive ALL and CML - 2022
    Completed
    • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    2022-03-25
    Mar 25, 2022